Articles sur sofosbuvir

Ensemble des articles

Despite global outrage at the cost of its Hepatitis C cure, Gilead reaps huge profits – aided by Australian taxpayer subsidies. Nick St Charles/flickr

Gilead and the billion-dollar odyssey

How much can a multinational take before its social licence to operate in this country expires? How much corporate welfare is too much?
The proposed Australian price for Sovaldi has not been disclosed, but in the United States a three-month course of treatment costs US$84,000. Stuart Hamilton/Flickr

What price a life? Hepatitis C drug out of reach for millions

It’s twice as common as type 1 diabetes. It kills more Australians than HIV. One in every 100 of us lives with hepatitis C, but the disease receives little attention. Worldwide, around 150 million people…

Les contributeurs les plus fréquents

Plus